Levels of HIV-1 in subgingival biofilm of HIV-infected patients

Journal of Clinical Periodontology

Volumn 41, Issue 11, 2014, Pages 1061-1068

  Pavan, Priscila ^a   Pereira, Viviane Tiago ^a   Souza, Rodrigo Carvalho ^b   Souza, Celso Oliveira ^a   Torres, Sandra Regina ^c   Colombo, Ana Paula Vieira ^c   Da Costa, Luciana Jesus ^c   Sansone, Carmelo ^a   Deuzeda, Milton ^b   Gonçalves, Lucio Souza ^b  

^a School of Dentistry São Leopoldo Mandic   (Brazil)

^b ESTÁCIO DE SÁ UNIVERSITY   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Chronic periodontitis; Haart; Hiv infection; Subgingival biofilm; Viral load

Indexed keywords

ADULT; BIOFILM; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CHRONIC PERIODONTITIS; CLASSIFICATION; COMPARATIVE STUDY; FEMALE; GINGIVA; GINGIVA BLEEDING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; LYMPHOCYTE COUNT; MALE; PATHOLOGY; PERIODONTAL DISEASE; PERIODONTAL POCKET; TOOTH PLAQUE; VIREMIA; VIROLOGY; VIRUS LOAD; YOUNG ADULT;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOFILMS; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC PERIODONTITIS; CLASSIFICATION; DENTAL PLAQUE; FEMALE; GINGIVA; GINGIVAL HEMORRHAGE; HIV INFECTIONS; HIV-1; HUMANS; ISOLATION AND PURIFICATION; LYMPHOCYTE COUNT; MALE; PATHOLOGY; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; VIRAL LOAD; VIREMIA; VIROLOGY; YOUNG ADULT;

EID: 84964265128     PISSN: 03036979     EISSN: 1600051X     Source Type: Journal    
DOI: 10.1111/jcpe.12306     Document Type: Article

References (57)

1. Aguiar, R. S., Costa, L. J., Pereira, H. S., Brindeiro, R. M. & Tanuri, A. (2007) Development of a new methodology for screening of human immunodeficiency virus type 1 microbicides based on real-time PCR quantification. Antimicrobial Agents and Chemotherapy 51, 638-644.
2. Alpagot, T., Duzgunes, N., Wolff, L. F. & Lee, A. (2004) Risk factors for periodontitis in HIV patients. Journal of Periodontal Research 39, 149-157.
3. Alpagot, T., Remien, J., Bhattacharyya, M., Konopka, K., Lundergan, W. & Duzgunes, N. (2007) Longitudinal evaluation of prostaglandin E2 (PGE2) and periodontal status in HIV+ patients. Archives of Oral Biology 52, 1102-1108.
4. Bagnarelli, P., Menzo, S., Valenza, A., Manzin, A., Giacca, M., Ancarani, F., Scalise, G., Varaldo, P. E. & Clementi, M. (1992) Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. Journal of Virology 66, 7328-7335.
5. Barr, C. E., Lopez, M. R., Rua-Dobles, A., Miller, L. K., Mathur-Wagh, U. & Turgeon, L. R. (1990) HIV-associated oral lesions: immunologic, virologic and salivary parameters. Journal of Oral Pathology and Medicine 21, 295-298.
6. Barr, C., Lopez, M. R. & Rua-Dobles, A. (1992) Periodontal changes by HIV serostatus in a cohort of homosexual and bisexual men. Journal of Clinical Periodontology 19, 794-801.
7. Begg, M., Panageas, K. S., Mitchell-Lew-Is, D., Buklan, R. S., Phelan, J. A. & Lamster, I. B. (1996) Oral lesions as markers of severe immunosuppression in HIV-infected homosexual men and injection drug users. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 82, 276-283.
8. Black, K. P., Merrill, K. W., Jackson, S. & Katz, J. (2000) Cytokine profiles in parotid saliva from HIV-1-infected individuals: changes associated with opportunistic infections in the oral cavity. Oral Microbiology and Immunology 15, 74-81.
9. Chermann, J. C., Barre-Sinoussi, F., Dauguet, C., Brun-Vezinet, F., Rouzioux, C., Rozenbaum, W. & Montagnier, L. (1983) Isolation of a new retrovirus in a patient at risk for acquired immunodeficiency syndrome. Antibiotic Chemotherapy 32, 48-53.
10. Cinque, P., Bossolasco, S. & Lundkvist, A. (2003) Molecular analysis of cerebrospinal fluid in viral diseases of the central nervous system. Journal of Clinical Virology 26, 1-2.
11. Contreras, A., Umeda, M., Chen, C., Bakker, I., Morrison, J. L. & Slots, J. (1999) Relationship between herpesviruses and adult periodontitis and periodontopathic bacteria. Journal of Periodontology 70, 478-484.
12. Coogan, M., Greenspan, J. & Challacombe, S. J. (2005) Oral lesions in infection with human immunodeficiency virus. Bulletin of the World Health Organization 83, 700-706.
13. Dar, O., Salaman, M. R., Seifert, M. H. & Isenberg, D. A. (1988) B lymphocyte activation in systemic lupus erythematosus: spontaneous production of IgG antibodies to DNA and environmental antigens in cultures of blood mononuclear cells. Clinical and Experimental Immunology 73, 430-435.
14. Farizo, K. M., Buehler, J. M., Chamberland, M. E., Whyte, B. M., Froelicher, E. S., Hopkins, S. G., Reed, C. M., Mokotoff, E. D., Cohn, D. L., Troxler, S., Phelps, A. F. & Berkelman, R. L. (1992) Spectrum of disease in persons with human immunodeficiency virus infection in the United States. Journal of the American Medical Association 267, 1798-1805.
15. Feigal, D. W., Katz, M. H., Greenspan, D., Westenhouse, J., Winkelstein, W. Jr, Lang, W., Samuel, M., Buchbinder, S. P., Hessol, N. A., Lifson, A. R., Rutherford, G. W., Moss, A., Osmond, D., Shiboski, S. & Greenspan, J. S. (1991) The prevalence of oral lesions in HIV-infected homosexuals and bisexual men: three San Francisco epidemiological cohorts. AIDS 5, 519-525.
16. Fricke, U., Geurtsen, W., Staufenbiel, I. & Rahman, A. (2012) Periodontal status of HIV-infected patients undergoing antiretroviral therapy compared to HIV-therapy naive patients: a case control study. European Journal of Medical Research 17, 2.
17. Glick, M., Muzyka, B. C., Lurie, D., Salkin, L. M. & Camden, N. J. (1994) Oral manifestations associated with related disease as markers for immune suppression and AIDS. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 77, 344-349.
18. Goncalves, L. S., Ferreira, S. M., Silva, A. Jr, Villoria, G. E., Costinha, L. H. & Colombo, A. P. (2005) Association of T CD4 lymphocyte levels and CP in HIV-infected brazilian patients undergoing highly active anti-retroviral therapy: clinical results. Journal of Periodontology 76, 915-922.
19. Goncalves, L. S., Ferreira, S. M., Souza, C. O., Souto, R. & Colombo, A. P. (2007) Clinical and microbiological profiles of human immunodeficiency virus (HIV)-seropositives Brazilians undergoing highly active antiretroviral therapy and HIV-seronegatives Brazilians with CP. Journal of Periodontology 78, 87-96.
20. Gonzalez, A. O., Ebersole, J. L. & Huang, C. B. (2009) Oral infectious diseases: a potential risk factor for HIV virus recrudescence. Oral Diseases 15, 313-327.
21. Groopman, J. E., Salahuddin, S. Z., Sarngadharan, M. G., Markham, P. D., Gonda, M., Sliski, A. & Gallo, R. C. (1984) HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS. Science 226, 477-479.
22. Hadley, W. K. (1989) Infection control issues for laboratory personnel. Occuptional Medicine 4(Suppl), 77-83.
23. Hammer, S. M., Squires, K. E., Hughes, M. D., Grimes, J. M., Demeter, L. M., Currier, J. S., Eron, J. J. Jr, Feinberg, J. E., Balfour, H. H. Jr, Deyton, L. R., Chodakewitz, J. A. & Fischl, M. A. (1997) A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. New England Journal of Medicine 337, 725-733.
24. Herzberg, M. C., Vacharaksa, A., Gebhard, K. H., Giacaman, R. A. & Ross, K. F. (2011) Plausibility of HIV-1 Infection of Oral Mucosal Epithelial Cells. Advances in Dental Research 23, 38-44.
25. Ho, D. D., Byington, R. E., Schooley, R. T., Flynn, T., Roto, T. R. & Hirsch, M. S. (1985) Infrequency of isolation of HTLV-III virus from saliva in AIDS. New England Journal of Medicine 313, 1606.
26. John, C. N., Stephen Xavier Graham, L. & Wilma Joyce Africa, C. (2012) BANA-Positive Plaque Samples Are Associated with Oral Hygiene Practices and Not CD4+ T Cell Counts in HIV-Positive Patients. International Journal of Dentistry 2012, 157-641.
27. Johnson, N. W. (1997) Essential questions concerning periodontal diseases in HIV infection. Oral Diseases 3(Suppl 1), S138-S140.
28. Jordan, L. (2013) Periodontal pathogens and reactivation of latent HIV infection: a review of the literature. Journal of Dental Hygiene 87, 59-63.
29. Kim, J. S., Nag, P., Landay, A. L., Alves, M., Cohn, M. H., Bremer, J. W. & Baum, L. L. (2006) Saliva can mediate HIV-1-specific antibody-dependent cell-mediated cytotoxicity. FEMS Immunology and Medical Microbiology 48, 267-273.
30. Kolokotronis, A., Kioses, V., Antoniades, D., Mandraveli, K., Doutsos, I. & Papanayotou, P. (1994) Immunologic status in patients infected with HIV with oral candidiasis and hairy leukoplakia. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 78, 41-46.
31. Levi, G. C. & Vitoria, M. A. (2002) Fighting against AIDS: the Brazilian experience. AIDS 16, 2373-2383.
32. Levy, J. A. & Greenspan, D. (1988) HIV in saliva. Lancet 332, 1248.
33. Liang, K. Y. & Zeger, S. L. (1986) Longitudinal data analysis using generalized linear models. Biometrics 73, 13-22.
34. Liuzzi, G., Chirianni, A., Clementi, M., Bagnarelli, P., Valenza, A., Cataldo, P. T. & Piazza, M. (1996) Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS 10, F51-F56.
35. Margiotta, V., Campisi, G., Mancuso, S., Accurso, V. & Abbadessa, V. (1999) HIV infection: oral lesions, CD4+ cell count and viral load in an Italian study population. Journal of Oral Pathology and Medicine 28, 173-177.
36. Maticic, M., Poljak, M., Kramar, B., Tomazic, J., Vidmar, L., Zakotnik, B. & Skaleric, U. (2000) Proviral HIV-1 DNA in GCFof HIV-1-infected patients in various stages of HIV disease. Journal of Dental Research 79, 1496-1501.
37. Mcneely, T. B., Dealy, M., Dripps, D. J., Orenstein, J. M., Eisenberg, S. P. & Wahl, S. M. (1995) Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. Journal of Clinical Investigation 96, 456-464.
38. Moniaci, D., Greco, D., Flecchia, G., Raiteri, R. & Sinicco, A. (1990) Epidemiology, clinical features and prognostic value of HIV-1 related oral lesions. Journal of Oral Pathology and Medicine 19, 477-481.
39. Nair, S., Faizuddin, M. & Dharmapalan, J. (2014) Role of autoimmune responses in periodontal disease. Autoimmune Diseases 2014, 596824.
40. Navazesh, M., Mulligan, R., Kono, N., Kumar, S. K. S., Nowicki, M., Alves, M. & Mack, W. J. (2010) Oral and systemic health correlates of HIV-1 shedding in saliva. Journal of Dental Research 89, 1074-1079.
41. Parra, B. & Slots, J. (1996) Detection of human viruses in periodontal pockets using polymerase chain reaction. Oral Microbiology and Immunology 5, 289-293.
42. Patton, L. L. (2000) Sensitivity, specificity, and positive predictive value of oral opportunistic infections in adults with HIV/AIDS as markers of immune suppression and viral burden. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 90, 182-188.
43. Pereira, V. T., Pavan, P., Souza, R. C., Souto, R., Vettore, M. V., Torres, S. R., Colombo, A. P., de Uzeda, M., Sansone, C. & Goncalves, L. S. (2014) The Association between detectable plasmatic HIV viral load and different subgingival microorganisms in HIV-Infected brazilian adults: a multilevel analysis. Journal of Periodontology 85, 697-705.
44. Perelson, A., Essunger, Y., Cao, Y., Vesanen, M., Hurley, A., Saksela, K., Markowitz, M. & Ho, D. D. (1997) Decay characteristics of HIV-1 infected compartments during combination therapy. Nature 387, 188-191.
45. Poggi, C., Profizi, N., Djediouane, A., Chollet, L., Hittinger, G. & Lafeuillade, A. (1999) Longterm evaluation of triple nucleoside therapy administered from primary HIV-1 infection. AIDS 13, 1213-1220.
46. Ramirez-Amador, V., Ponce-De-Leon, S., Sierra-Madero, J., Soto-Ramirez, L., Esquivel-Pedraza, L. & Anaya-Saavedra, G. (2005) Synchronous kinetics of CD4+ lymphocytes and viral load before the onset of oral candidosis and hairy leukoplakia in a cohort of Mexican HIV-infected patients. AIDS Research and Human Retroviruses 21, 981-990.
47. Reznik, D. A. (2005) Oral manifestations of HIV disease. Topics in HIV Medicine 13, 143-148.
48. Ryder, M. I. (2002) An update on HIV and periodontal disease. Journal of Periodontology 73, 1071-1078.
49. Schacker, T., Collier, A. C., Hughes, J., Shea, T. & Corey, L. (1996) Clinical and epidemiologic features of primary HIV infection. Annals of Internal Medicine 125, 257-264.
50. Shen, X. & Tomaras, G. D. (2011) Alterations of the B-cell response by HIV-1 replication. Current HIV/AIDS Reports 8, 23-30.
51. Shirai, A., Cosentino, M., Leitman-Klinman, S. F. & Klinman, D. M. (1992) Human immunodeficiency virus infection induces both polyclonal and virus specific B cell ativation. Journal of Clinical Investigation 89, 561-566.
52. Shugars, D. C., Alexander, A. L., Fu, K. & Freel, S. A. (1999) Endogenous salivary inhibitors of human immunodeficiency virus. Archives Oral Biology 44, 445-453.
53. Shugars, D. C., Patton, L. L., Freel, S. A., Gray, L. R., Vollmer, R. T., Eron, J. J. Jr & Fiscus, S. A. (2001) Hyperexcretion of human immunodeficiency virus type 1 RNA in saliva. Journal of Dental Research 80, 414-420.
54. Sugawara, M., Yamashita, K., Yoshie, H. & Hara, K. (1992) Detection of, and anti-collagen antibody produced by, CD5-positive B cells in inflamed gingival tissues. Journal of Periodontal Research 27, 489-498.
55. UNAIDS (2008) Report on the global HIV/AIDS epidemic.
56. UNAIDS (2010) Global summary of the AIDS epidemic.
57. Zeger, S. L. & Liang, K. Y. (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42, 121-130.